Loading clinical trials...
Loading clinical trials...
The purpose is to explore the frequency of impulse control disorders in Parkinson's patients treated with different Parkinson's medications.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Boehringer Ingelheim
NCT07187843 · Parkinson Disease, Parkinsonian Disorders, and more
NCT07545473 · Dementia, Neurodegenerative Diseases, and more
NCT07543861 · Parkinson Disease
NCT05748028 · Parkinson Disease, Multiple System Atrophy
NCT07495462 · Parkinson Disease (PD)
248.619.01034 Neurological Physicians of Arizona
Gilbert, Arizona
248.619.01007 Mayo Clinic - Scottsdale
Scottsdale, Arizona
248.619.01025 Sun Health Research Institute
Sun City, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions